We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-14.6%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$9.8B
AUM Growth
-$1.96B
(-17%)
Cap. Flow
-$53.6M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
15.05%
Holding
1,967
New
854
Increased
344
Reduced
350
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$97.9M |
| 2 |
SHPG
Shire pic
SHPG
|
+$80.3M |
| 3 |
Teleflex
TFX
|
+$76.7M |
| 4 |
Accenture
ACN
|
+$74.6M |
| 5 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$74.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$140M |
| 2 |
Quest Diagnostics
DGX
|
+$97.7M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$94.3M |
| 4 |
Tractor Supply
TSCO
|
+$78.2M |
| 5 |
AET
Aetna Inc
AET
|
+$77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.48% |
| 2 | Consumer Discretionary | 18.77% |
| 3 | Technology | 12.96% |
| 4 | Financials | 11.62% |
| 5 | Industrials | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Integra LifeSciences
IART
$1.54B
| $6.47M | 0.07% |
+143,426
| New | +$7.87M |
|
|
HUD
377
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $6.43M | 0.07% |
374,798
-238,490
| -39% | -$4.69M |
|
378
Mondelez International
MDLZ
$77.7B
| $6.4M | 0.07% |
159,968
-739,154
| -82% | -$31.5M |
|
379
HF Sinclair
DINO
$15.9B
| $6.34M | 0.06% |
+123,946
| New | +$7.59M |
|
380
MiMedx Group
MDXG
$626M
| $6.33M | 0.06% |
+3,538,354
| New | +$19.6M |
|
381
Comtech Telecommunications
CMTL
$51.8M
| $6.33M | 0.06% |
259,924
+67,552
| +35% | +$1.89M |
|
382
Rush Enterprises Class A
RUSHA
$5.95B
| $6.3M | 0.06% |
411,280
-455,560
| -53% | -$7.28M |
|
383
First Citizens BancShares
FCNCA
$24.6B
| $6.28M | 0.06% |
16,665
-18,228
| -52% | -$7.66M |
|
|
MLNX
384
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $6.25M | 0.06% |
+67,717
| New | +$5.75M |
|
|
HSII
385
DELISTED
Heidrick & Struggles
HSII
| $6.25M | 0.06% |
+200,425
| New | +$6.56M |
|
|
OMAD.U
386
DELISTED
One Madison Corporation
OMAD.U
| $6.24M | 0.06% |
600,000
| – | – |
|
|
ZEN
387
DELISTED
ZENDESK INC
ZEN
| $6.22M | 0.06% |
+106,624
| New | +$6.14M |
|
|
ACOR
388
DELISTED
Acorda Therapeutics
ACOR
| $6.21M | 0.06% |
+3,322
| New | +$7.23M |
|
389
New Oriental
EDU
$7.84B
| $6.21M | 0.06% |
113,295
+5,920
| +6% | +$343K |
|
|
CTRL
390
DELISTED
Control4 Corporation
CTRL
| $6.2M | 0.06% |
352,346
+243,781
| +225% | +$5.77M |
|
391
CALL
SPDR Gold Trust
GLD
$131B
| $6.17M | 0.06% |
+50,000
| New | +$5.81M |
|
|
WCG
392
DELISTED
Wellcare Health Plans, Inc.
WCG
| $6.14M | 0.06% |
26,012
-351,850
| -93% | -$94.3M |
|
393
Arcos Dorados Holdings
ARCO
$1.73B
| $6.14M | 0.06% |
798,599
-263,399
| -25% | -$1.88M |
|
|
VRS
394
DELISTED
Verso Corporation
VRS
| $6.13M | 0.06% |
+273,799
| New | +$7.4M |
|
395
Nektar Therapeutics
NKTR
$2.39B
| $6.1M | 0.06% |
+12,374
| New | +$7.47M |
|
|
TIF
396
DELISTED
Tiffany & Co.
TIF
| $6.03M | 0.06% |
74,864
-20,401
| -21% | -$2.08M |
|
|
SP
397
DELISTED
SP Plus Corporation
SP
| $5.99M | 0.06% |
202,815
+181,572
| +855% | +$5.63M |
|
398
Accuray
ARAY
$28.4M
| $5.92M | 0.06% |
1,736,839
+1,193,622
| +220% | +$4.84M |
|
399
National Beverage
FIZZ
$2.87B
| $5.92M | 0.06% |
+164,908
| New | +$7.6M |
|
|
IRBT
400
DELISTED
iRobot
IRBT
| $5.89M | 0.06% |
+70,293
| New | +$6.37M |
|
Similar funds
Marshall Wace's Q4 2018 Portfolio in Review
As of Q4 2018, Marshall Wace held 1,967 positions worth $9.8B, down 17% from $11.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Marshall Wace's Q4 2018 filing shows 854 new, 344 increased, 350 reduced and 392 closed positions. Its largest new stake was Mastercard: 339,646 shares worth $64.1M. The largest sale was McDonald's, an estimated $140M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Technology.
- Marshall Wace's largest Q4 2018 buy was Mastercard: 339,646 shares worth $64.1M.
- Marshall Wace added most to Alphabet (Google) Class A in Q4 2018, an estimated $97.9M increase.
- Marshall Wace's biggest Q4 2018 reduction was McDonald's, cutting an estimated $140M.
- Marshall Wace fully exited Aetna Inc in Q4 2018, selling an estimated $77M.
- Marshall Wace's ten largest holdings make up 15% of its $9.8B portfolio in Q4 2018.
- Marshall Wace opened 854 new positions and closed 392 in Q4 2018.
- Marshall Wace's portfolio value fell 17% quarter-over-quarter to $9.8B.
Based on Marshall Wace's 13F filing for Q4 2018, filed 14 Feb 2019.